The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sarcoma Oncology Center
Leadership - Sarcoma Oncology Center
Stock and Other Ownership Interests - AADi

Initial results of a phase III investigation of safety/efficacy of nivolumab and ABI-009 (nab-sirolimus) in advanced undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), chondrosarcoma (CS), osteosarcoma (OS), and Ewing sarcoma.
 
Victoria S. Chua-Alcala
No Relationships to Disclose
 
Katherine Kim
No Relationships to Disclose
 
Nupur Assudani
No Relationships to Disclose
 
Ahmad Al-Shihabi
No Relationships to Disclose
 
Doris Quon
No Relationships to Disclose
 
Steven Wong
No Relationships to Disclose
 
Sant P. Chawla
No Relationships to Disclose
 
Erlinda Maria Gordon
No Relationships to Disclose